Non-Invasive Fetal Membranes Rupture Tests — CPB 0757 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0757 covering non-invasive fetal membrane rupture tests, effective November 14, 2025. Every test in this category — including AmniSure ROM, Actim PROM, ROM Plus, and Chorioquick — is now explicitly classified as experimental, investigational, or unproven. CPT 84112 is the primary code your billing team needs to watch.

If you bill CPT 84112 or order fetal MRI studies (CPT 74712, 74713) for Aetna members with preterm premature rupture of membranes (PPROM), this update closes coverage doors that may have been open under prior policy language. Here's what changes for billing teams.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Non-Invasive Fetal Membranes Rupture Tests
Policy Code	CPB 0757
Change Type	Modified
Effective Date	November 14, 2025
Impact Level	High
Specialties Affected	OB/GYN, Maternal-Fetal Medicine, Labor & Delivery, Radiology
Key Action	Remove CPT 84112 from standard charge capture for Aetna PPROM workups and flag CPT 74712, 74713, 76391, 76811–76812, and 76981–76983 as non-covered for ROM indications before billing

---

Aetna Non-Invasive Fetal Membrane Rupture Test Coverage Criteria and Medical Necessity Requirements 2025

The core of this Aetna fetal membrane rupture coverage policy is a blanket denial. Aetna does not cover any non-invasive test for detecting preterm rupture of membranes (ROM) under any indication. That's not an overstatement — the policy language says "for detecting preterm ROM and all other indications."

This matters for medical necessity arguments. You will not build a successful appeal by documenting clinical urgency or high-risk pregnancy status. Aetna's position is that the evidence base doesn't support these tests — not that the tests are covered only in certain clinical scenarios. Medical necessity criteria don't apply here because Aetna has classified the entire category as experimental.

The Aetna fetal membrane rupture billing problem is straightforward: claims for CPT 84112 (evaluation of cervicovaginal fluid for specific amniotic fluid proteins, such as placental alpha microglobulin-1) submitted with ROM-related ICD-10 codes will deny. So will claims for fetal MRI studies (CPT 74712 and 74713) billed for PPROM evaluation. There's no prior authorization pathway that unlocks coverage — prior authorization for experimental services doesn't produce approvals, it produces denials with documentation.

The effective date of November 14, 2025 means this is already in force. If your team has been billing these tests against Aetna, your aging AR deserves a review right now.

---

Aetna Non-Invasive Fetal Membrane Rupture Test Exclusions and Non-Covered Indications

This is where CPB 0757 does the real damage. Aetna has drawn a wide circle around everything in this space.

The specific technologies called out by name:

These are the four most widely used point-of-care PPROM tests in U.S. labor and delivery settings. Aetna has named all of them explicitly. That's not accidental — it closes the argument that an unnamed test might be covered.

The imaging technologies called out:

Two additional exclusions your clinical team should know:

First, Aetna classifies evaluation of vaginal microbiome profiles for detecting preterm ROM as experimental. If your institution is running any research-adjacent testing in this area for Aetna members, bill carefully — or don't bill Aetna at all.

Second, amniotic fluid soluble urokinase-type plasminogen activator receptor (suPAR) for diagnosing fetal inflammatory response syndrome (FIRS) is explicitly excluded. The ICD-10 codes for FIRS — a long list of O36.89xx codes — appear in the policy's code table. Aetna is signaling that FIRS-related diagnostic workups using suPAR won't get reimbursement under this or related policies.

The Biobeat Monitoring Platform for ROM monitoring also appears on the experimental list. This is a wearable biosensor platform. If your hospital or practice has piloted Biobeat for any pregnancy monitoring application, don't bill Aetna for ROM-related use.

---

Coverage Indications at a Glance

---

Aetna Fetal Membrane Rupture Billing Guidelines and Action Items 2025

This policy is already active. Don't wait to act on this.

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for Fetal Membrane Rupture Tests Under CPB 0757

Not Covered / Experimental CPT Codes

All nine CPT codes in this policy fall under the experimental, investigational, or unproven designation. There are no covered CPT codes listed in CPB 0757.

Key ICD-10-CM Diagnosis Codes

The policy lists 190 ICD-10-CM codes. The full range spans pregnancy and obstetric complication codes (O00–O9A) and supervision of pregnancy codes (Z34). High-priority codes for billing teams are listed below, including the FIRS-specific code set.

The O36.89xx series is the FIRS-specific code block. Aetna explicitly called out suPAR testing for FIRS diagnosis as experimental. If your maternal-fetal medicine team orders suPAR panels for Aetna members using these codes, expect denials and no covered reimbursement path.

One practical note on the ultrasound codes: CPT 76811 and 76812 are not globally non-covered. Aetna covers standard fetal anatomy ultrasound. The denial risk is specific to claims where the documented indication is ROM detection or membrane assessment. Your ICD-10 coding has to be precise. A 76811 billed for a routine anatomy scan with a standard dating or anatomy code will process differently than one billed with a PPROM diagnosis code. Train your coders on this distinction now.

---